Personal tools
You are here: Home / Labs / Organometallic Catalysis

Organometallic Catalysis

The Organometallic Catalysis Group works on the synthesis of organometallic compounds with specific properties for their use in catalytic and biological applications. We develop new catalytic systems using Earth-abundant 3d metals for the functionalization of organic molecules. We are also interested in developing new metal-based drugs for the treatment of human diseases, such as cancer and microbial infections.

Our ongoing research lines are:

I.  Coordination chemistry of first row transition metals (Mn, Fe, Co, and Ni) with N-heterocyclic carbene ligands (NHC) and mesoionic carbenes (MIC).

II. Development of sustainable catalytic methods based on Earth-abundant, cheap metals. 

III. Development of catalytic processes for CO2 valorisation and H2 production.

IV. Manganese complexes as new drugs against antimicrobial resistance.

V. Organometallic complexes as anticancer drugs.

Recent achivements:

- Selective reduction of functional groups catalysed by manganese, iron and nickel complexes: Angew. Chem. Int. Ed. 2018, 57 (13), 4603-4606; ChemCatChem 2018, 10 (13), 2734-2740; ChemCatChem 20179, 3073-3077.

- Selective oxidation reactions with Earth-abundant metal-based catalysts (Ti,  Mn, Fe): Catal. Sci. Technol. 2019, DOI: 10.1039/C9CY00685K5; Dalton Trans. 2016, 45, 13541; Catal. Sci. Technol. 2015, 5, 320.

- Development of water soluble organometallic complexes and their application in borrowing hydrogen processes: ChemCatChem 2017, 9, 3912-3917.





Document Actions